Dostarlimab with platinum-containing chemotherapy for treating primary advanced or recurrent endometrial cancer with microsatellite stability or mismatch repair proficiency. NICE technology appraisal guidance 1117
National Institute for Health and Care Excellence (NICE)
Record ID 32018014843
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/ta1117
Year Published:
2025
URL for published report:
https://www.nice.org.uk/guidance/ta1117
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Endometrial Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- Antibodies, Monoclonal, Humanized
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
3rd floor, 3 Piccadilly Place, Manchester, M1 3BN
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.